Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Development of Nationwide Recommendations to Support Prenatal Counseling in Extreme Prematurity.

Geurtzen R, van Heijst AFJ, Draaisma JMT, Kuijpers LJMK, Woiski M, Scheepers HCJ, van Kaam AH, Oudijk MA, Lafeber HN, Bax CJ, Koper JF, Duin LK, van der Hoeven MA, Kornelisse RF, Duvekot JJ, Andriessen P, van Runnard Heimel PJ, van der Heide-Jalving M, Bekker MN, Mulder-de Tollenaer SM, van Eyck J, Eshuis-Peters E, Graatsma M, Hermens RPMG, Hogeveen M.

Pediatrics. 2019 Jun;143(6). pii: e20183253. doi: 10.1542/peds.2018-3253.

PMID:
31160512
2.

Women's experiences of monitoring the small-for-gestational age fetus by ultrasound: A qualitative study.

Vollgraff Heidweiller-Schreurs CA, de Boer MA, van der Meij KRM, Bax CJ, de Groot CJM, Henneman L.

PLoS One. 2019 May 1;14(5):e0216052. doi: 10.1371/journal.pone.0216052. eCollection 2019.

3.

Amnioinfusion Compared With No Intervention in Women With Second-Trimester Rupture of Membranes: A Randomized Controlled Trial.

van Kempen LEM, van Teeffelen AS, de Ruigh AA, Oepkes D, Haak MC, van Leeuwen E, Woiski M, Porath MM, Bax CJ, van Wassenaer-Leemhuis AG, Mulder AL, van der Ham DP, Willekes C, Franssen MT, Derks JB, Schuit E, Mol BW, Pajkrt E.

Obstet Gynecol. 2019 Jan;133(1):129-136. doi: 10.1097/AOG.0000000000003003.

PMID:
30531572
4.

Doppler measurements of both umbilical arteries do not improve predictive value for adverse perinatal outcomes in small-for-gestational age fetuses.

Vollgraff Heidweiller-Schreurs CA, van Maasakker NE, van de Ven PM, de Groot CJM, Bax CJ, de Boer MA.

Eur J Obstet Gynecol Reprod Biol. 2018 Dec;231:169-173. doi: 10.1016/j.ejogrb.2018.10.040. Epub 2018 Oct 25.

PMID:
30391865
5.

Fetal megacystis: a lot more than LUTO.

Fontanella F, Maggio L, Verheij JBGM, Duin LK, Adama Van Scheltema PN, Cohen-Overbeek TE, Pajkrt E, Bekker M, Willekes C, Bax CJ, Gracchi V, Oepkes D, Bilardo CM.

Ultrasound Obstet Gynecol. 2019 Jun;53(6):779-787. doi: 10.1002/uog.19182.

6.

Antenatal Workup of Early Megacystis and Selection of Candidates for Fetal Therapy.

Fontanella F, Duin L, Adama van Scheltema PN, Cohen-Overbeek TE, Pajkrt E, Bekker M, Willekes C, Bax CJ, Oepkes D, Bilardo CM.

Fetal Diagn Ther. 2019;45(3):155-161. doi: 10.1159/000488282. Epub 2018 May 17.

7.

Prenatal diagnosis of LUTO: improving diagnostic accuracy.

Fontanella F, Duin LK, Adama van Scheltema PN, Cohen-Overbeek TE, Pajkrt E, Bekker M, Willekes C, Bax CJ, Gracchi V, Oepkes D, Bilardo CM.

Ultrasound Obstet Gynecol. 2018 Dec;52(6):739-743. doi: 10.1002/uog.18990. Epub 2018 Nov 9.

8.

Prognostic accuracy of cerebroplacental ratio and middle cerebral artery Doppler for adverse perinatal outcome: systematic review and meta-analysis.

Vollgraff Heidweiller-Schreurs CA, De Boer MA, Heymans MW, Schoonmade LJ, Bossuyt PMM, Mol BWJ, De Groot CJM, Bax CJ.

Ultrasound Obstet Gynecol. 2018 Mar;51(3):313-322. doi: 10.1002/uog.18809. Epub 2018 Feb 5. Review.

9.

Cost-effectiveness of diagnostic testing strategies including cervical-length measurement and fibronectin testing in women with symptoms of preterm labor.

van Baaren GJ, Vis JY, Wilms FF, Oudijk MA, Kwee A, Porath MM, Scheepers HCJ, Spaanderman MEA, Bloemenkamp KWM, Haak MC, Bax CJ, Cornette JMJ, Duvekot JJ, Nij Bijvanck BWA, van Eyck J, Franssen MTM, Sollie KM, Vandenbussche FPHA, Woiski M, Bolte AC, van der Post JAM, Bossuyt PMM, Opmeer BC, Mol BWJ.

Ultrasound Obstet Gynecol. 2018 May;51(5):596-603. doi: 10.1002/uog.17481. Epub 2018 Mar 30.

10.

Fetal megacystis: prediction of spontaneous resolution and outcome.

Fontanella F, Duin L, Adama van Scheltema PN, Cohen-Overbeek TE, Pajkrt E, Bekker M, Willekes C, Bax CJ, Bilardo CM.

Ultrasound Obstet Gynecol. 2017 Oct;50(4):458-463. doi: 10.1002/uog.17422. Epub 2017 Sep 5.

11.

Pregnancy complications in singleton pregnancies with isolated fetal heart defects.

van Velzen CL, Türkeri F, Pajkrt E, Clur SA, Rijlaarsdam ME, Bax CJ, Hruda J, de Groot CJ, Blom NA, Haak MC.

Acta Obstet Gynecol Scand. 2016 Nov;95(11):1273-1280. doi: 10.1111/aogs.12955. Epub 2016 Sep 1.

PMID:
27496177
12.

Quantitative fetal fibronectin testing in combination with cervical length measurement in the prediction of spontaneous preterm delivery in symptomatic women.

Bruijn M, Vis JY, Wilms FF, Oudijk MA, Kwee A, Porath MM, Oei G, Scheepers H, Spaanderman M, Bloemenkamp K, Haak MC, Bolte AC, Vandenbussche F, Woiski MD, Bax CJ, Cornette J, Duvekot JJ, Nij Bijvanck B, van Eyck J, Franssen M, Sollie KM, van der Post J, Bossuyt P, Opmeer BC, Kok M, Mol B, van Baaren GJ.

BJOG. 2016 Nov;123(12):1965-1971. doi: 10.1111/1471-0528.13752. Epub 2015 Dec 15.

13.

Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part I-clinical impact.

Oepkes D, Page-Christiaens GC, Bax CJ, Bekker MN, Bilardo CM, Boon EM, Schuring-Blom GH, Coumans AB, Faas BH, Galjaard RH, Go AT, Henneman L, Macville MV, Pajkrt E, Suijkerbuijk RF, Huijsdens-van Amsterdam K, Van Opstal D, Verweij EJ, Weiss MM, Sistermans EA; and for the Dutch NIPT Consortium.

Prenat Diagn. 2016 Dec;36(12):1083-1090. doi: 10.1002/pd.4945. Epub 2016 Nov 15.

14.

Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.

Bruijn MM, Vis JY, Wilms FF, Oudijk MA, Kwee A, Porath MM, Oei G, Scheepers HC, Spaanderman ME, Bloemenkamp KW, Haak MC, Bolte AC, Vandenbussche FP, Woiski MD, Bax CJ, Cornette JM, Duvekot JJ, Nij Bijvank BW, van Eyck J, Franssen MT, Sollie KM, van der Post JA, Bossuyt PM, Opmeer BC, Kok M, Mol BW, van Baaren GJ.

Eur J Obstet Gynecol Reprod Biol. 2016 Nov;206:220-224. doi: 10.1016/j.ejogrb.2016.09.018. Epub 2016 Sep 20.

PMID:
27750180
15.

Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial: Assessment of perinatal outcome by use of tocolysis in early labor-APOSTEL IV trial.

Nijman TA, van Vliet EO, Naaktgeboren CA, Oude Rengerink K, de Lange TS, Bax CJ, Bloemenkamp KW, van Eyck J, Kok M, Scheepers HC, Woiski M, Franx A, Mol BW, Oudijk MA.

Eur J Obstet Gynecol Reprod Biol. 2016 Oct;205:79-84. doi: 10.1016/j.ejogrb.2016.08.024. Epub 2016 Aug 9.

PMID:
27567363
16.

Which Factors Contribute to False-Positive, False-Negative, and Invalid Results in Fetal Fibronectin Testing in Women with Symptoms of Preterm Labor?

Bruijn MM, Hermans FJ, Vis JY, Wilms FF, Oudijk MA, Kwee A, Porath MM, Oei G, Scheepers HC, Spaanderman ME, Bloemenkamp KW, Haak MC, Bolte AC, Vandenbussche FP, Woiski MD, Bax CJ, Cornette JM, Duvekot JJ, Bijvank BW, van Eyck J, Franssen MT, Sollie KM, van der Post JA, Bossuyt PM, Kok M, Mol BW, van Baaren GJ.

Am J Perinatol. 2017 Feb;34(3):234-239. doi: 10.1055/s-0036-1585466. Epub 2016 Jul 21.

PMID:
27441567
17.

Effectiveness of a cervical pessary for women who did not deliver 48 h after threatened preterm labor (Assessment of perinatal outcome after specific treatment in early labor: Apostel VI trial).

Hermans FJ, Schuit E, Opmeer BC, Oudijk MA, Bekker M, Woiski M, Bax CJ, Sueters M, Scheepers HC, Franssen MT, Pajkrt E, Mol BW, Kok M.

BMC Pregnancy Childbirth. 2016 Jul 12;16(1):154. doi: 10.1186/s12884-016-0935-7.

18.

A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical Practice.

Rebers S, Vermeulen E, Brandenburg AP, Stoof TJ, Zupan-Kajcovski B, Bos WJ, Jonker MJ, Bax CJ, van Driel WJ, Verwaal VJ, van den Brekel MW, Grutters JC, Tupker RA, Plusjé L, de Bree R, Schagen van Leeuwen JH, Vermeulen EG, de Leeuw RA, Brohet RM, Aaronson NK, Van Leeuwen FE, Schmidt MK.

PLoS One. 2016 Mar 30;11(3):e0152509. doi: 10.1371/journal.pone.0152509. eCollection 2016.

19.

Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial.

van Vliet EOG, Nijman TAJ, Schuit E, Heida KY, Opmeer BC, Kok M, Gyselaers W, Porath MM, Woiski M, Bax CJ, Bloemenkamp KWM, Scheepers HCJ, Jacquemyn Y, Beek EV, Duvekot JJ, Franssen MTM, Papatsonis DN, Kok JH, van der Post JAM, Franx A, Mol BW, Oudijk MA.

Lancet. 2016 May 21;387(10033):2117-2124. doi: 10.1016/S0140-6736(16)00548-1. Epub 2016 Mar 2.

PMID:
26944026
20.

The impact of fetal gender and ethnicity on the risk of spontaneous preterm delivery in women with symptoms of preterm labor.

Wilms FF, Vis JY, Oudijk MA, Kwee A, Porath MM, Scheepers HC, Spaanderman ME, Bloemenkamp KW, Bolte AC, Bax CJ, Cornette JM, Duvekot JJ, Nij Bijvanck BW, Eijck Jv, Franssen MT, Sollie KM, Vandenbussche FP, Woiski MD, van der Post JA, Bossuyt PM, Opmeer BC, Mol BW, van Baaren GJ.

J Matern Fetal Neonatal Med. 2016 Nov;29(21):3563-9. doi: 10.3109/14767058.2016.1139566. Epub 2016 Feb 24.

PMID:
26911700
21.

Early nasogastric tube feeding in optimising treatment for hyperemesis gravidarum: the MOTHER randomised controlled trial (Maternal and Offspring outcomes after Treatment of HyperEmesis by Refeeding).

Grooten IJ, Mol BW, van der Post JAM, Ris-Stalpers C, Kok M, Bais JMJ, Bax CJ, Duvekot JJ, Bremer HA, Porath MM, Heidema WM, Bloemenkamp KWM, Scheepers HCJ, Franssen MTM, Oudijk MA, Roseboom TJ, Painter RC.

BMC Pregnancy Childbirth. 2016 Jan 27;16:22. doi: 10.1186/s12884-016-0815-1.

22.

Pessary placement in the prevention of preterm birth in multiple pregnancies: a propensity score analysis.

Monfrance MJ, Schuit E, Groenwold RH, Oudijk MA, de Graaf IM, Bax CJ, Bekedam DJ, Mol BW, Langenveld J.

Eur J Obstet Gynecol Reprod Biol. 2016 Feb;197:72-7. doi: 10.1016/j.ejogrb.2015.11.001. Epub 2015 Nov 30.

PMID:
26706925
23.

Prenatal diagnosis of congenital heart defects: accuracy and discrepancies in a multicenter cohort.

van Velzen CL, Clur SA, Rijlaarsdam ME, Pajkrt E, Bax CJ, Hruda J, de Groot CJ, Blom NA, Haak MC.

Ultrasound Obstet Gynecol. 2016 May;47(5):616-22. doi: 10.1002/uog.15742.

24.

Behavioural and neurodevelopmental outcome of 2-year-old children after preterm premature rupture of membranes: follow-up of a randomised clinical trial comparing induction of labour and expectant management.

van der Heyden JL, Willekes C, van Baar AL, van Wassenaer-Leemhuis AG, Pajkrt E, Oudijk MA, Porath MM, Duvekot HJ, Bloemenkamp KW, Groenewout M, Woiski M, Nij Bijvank B, Bax CJ, van 't Hooft J, Sikkema MJ, Akerboom BM, Mulder TA, Nijhuis JG, Mol BW, van der Ham DP.

Eur J Obstet Gynecol Reprod Biol. 2015 Nov;194:17-23. doi: 10.1016/j.ejogrb.2015.07.014. Epub 2015 Aug 3.

PMID:
26319651
25.

Risk factors for preterm delivery: do they add to fetal fibronectin testing and cervical length measurement in the prediction of preterm delivery in symptomatic women?

van Baaren GJ, Bruijn MM, Vis JY, Wilms FF, Oudijk MA, Kwee A, Porath MM, Oei G, Scheepers HC, Spaanderman ME, Bloemenkamp KW, Haak MC, Bolte AC, Bax CJ, Cornette JM, Duvekot JJ, Nij Bijvanck BW, van Eijck J, Franssen MT, Sollie KM, Vandenbussche FP, Woiski M, Bossuyt PM, Opmeer BC, Mol BW.

Eur J Obstet Gynecol Reprod Biol. 2015 Sep;192:79-85. doi: 10.1016/j.ejogrb.2015.05.004. Epub 2015 Jun 10.

PMID:
26182836
26.

Prescribing patterns of antenatal corticosteroids in women with threatened preterm labor.

Wilms FF, van Baaren GJ, Vis JY, Oudijk MA, Kwee A, Porath MM, Scheepers HC, Spaanderman ME, Bloemenkamp KW, Bolte AC, Bax CJ, Cornette JM, Duvekot JJ, Nij Bijvank BW, van Eyck J, Franssen MT, Sollie KM, Vandenbussche FP, Woiski MD, van der Post JA, Bossuyt PM, Opmeer BC, Mol BW.

Eur J Obstet Gynecol Reprod Biol. 2015 Sep;192:47-53. doi: 10.1016/j.ejogrb.2015.06.008. Epub 2015 Jun 17.

PMID:
26149479
27.

Risk stratification with cervical length and fetal fibronectin in women with threatened preterm labor before 34 weeks and not delivering within 7 days.

Hermans FJR, Bruijn MMC, Vis JY, Wilms FF, Oudijk MA, Porath MM, Scheepers HCJ, Bloemenkamp KWM, Bax CJ, Cornette JMJ, Nij Bijvanck BWA, Franssen MTM, Vandenbussche FPHA, Kok M, Grobman WA, Van Der Post JAM, Bossuyt PMM, Opmeer BC, Mol BWJ, Schuit E, Van Baaren GJ.

Acta Obstet Gynecol Scand. 2015 Jul;94(7):715-721. doi: 10.1111/aogs.12643. Epub 2015 Apr 29.

PMID:
25845495
28.

Prenatal detection of congenital heart disease--results of a national screening programme.

van Velzen CL, Clur SA, Rijlaarsdam ME, Bax CJ, Pajkrt E, Heymans MW, Bekker MN, Hruda J, de Groot CJ, Blom NA, Haak MC.

BJOG. 2016 Feb;123(3):400-7. doi: 10.1111/1471-0528.13274. Epub 2015 Jan 27.

29.

Randomized comparison of nifedipine and placebo in fibronectin-negative women with symptoms of preterm labor and a short cervix (APOSTEL-I Trial).

Vis JY, van Baaren GJ, Wilms FF, Oudijk MA, Kwee A, Porath MM, Scheepers HC, Spaanderman ME, Bloemenkamp KW, van Lith JM, Bolte AC, Bax CJ, Cornette J, Duvekot JJ, Nij Bijvank SW, van Eyck J, Franssen MT, Sollie KM, Woiski M, Vandenbussche FP, van der Post JA, Bossuyt PM, Opmeer BC, Mol BW.

Am J Perinatol. 2015 Apr;32(5):451-60. doi: 10.1055/s-0034-1390346. Epub 2014 Dec 8.

PMID:
25486290
30.

Prenatal detection of transposition of the great arteries reduces mortality and morbidity.

van Velzen CL, Haak MC, Reijnders G, Rijlaarsdam ME, Bax CJ, Pajkrt E, Hruda J, Galindo-Garre F, Bilardo CM, de Groot CJ, Blom NA, Clur SA.

Ultrasound Obstet Gynecol. 2015 Mar;45(3):320-5. doi: 10.1002/uog.14689. Epub 2015 Jan 27.

31.

Predictive value of cervical length measurement and fibronectin testing in threatened preterm labor.

van Baaren GJ, Vis JY, Wilms FF, Oudijk MA, Kwee A, Porath MM, Oei G, Scheepers HC, Spaanderman ME, Bloemenkamp KW, Haak MC, Bolte AC, Bax CJ, Cornette JM, Duvekot JJ, Nij Bijvanck BW, van Eyck J, Franssen MT, Sollie KM, Vandenbussche FP, Woiski M, Grobman WA, van der Post JA, Bossuyt PM, Opmeer BC, Mol BW.

Obstet Gynecol. 2014 Jun;123(6):1185-92. doi: 10.1097/AOG.0000000000000229.

PMID:
24807328
32.

Midtrimester preterm prelabour rupture of membranes (PPROM): expectant management or amnioinfusion for improving perinatal outcomes (PPROMEXIL - III trial).

van Teeffelen AS, van der Ham DP, Willekes C, Al Nasiry S, Nijhuis JG, van Kuijk S, Schuyt E, Mulder TL, Franssen MT, Oepkes D, Jansen FA, Woiski MD, Bekker MN, Bax CJ, Porath MM, de Laat MW, Mol BW, Pajkrt E.

BMC Pregnancy Childbirth. 2014 Apr 4;14:128. doi: 10.1186/1471-2393-14-128.

33.

Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial).

van Vliet EO, Schuit E, Heida KY, Opmeer BC, Kok M, Gyselaers W, Porath MM, Woiski M, Bax CJ, Bloemenkamp KW, Scheepers HC, Jaquemyn Y, van Beek E, Duvekot HJ, Franssen MT, Bijvank BN, Kok JH, Franx A, Mol BW, Oudijk MA.

BMC Pregnancy Childbirth. 2014 Mar 3;14:93. doi: 10.1186/1471-2393-14-93.

34.

Serovar D and E of serogroup B induce highest serological responses in urogenital Chlamydia trachomatis infections.

Verweij SP, Lanjouw E, Bax CJ, Quint KD, Oostvogel PM, Dörr PJ, Pleijster J, de Vries HJ, Peters RP, Ouburg S, Morré SA.

BMC Infect Dis. 2014 Jan 2;14:3. doi: 10.1186/1471-2334-14-3.

35.

Serogroup distribution of urogenital Chlamydia trachomatis in urban ethnic groups in The Netherlands.

Verweij SP, Quint KD, Bax CJ, Van Leeuwen AP, Mutsaers JA, Jansen CL, Oostvogel PM, Ouburg S, Morré SA, Peters RP.

Epidemiol Infect. 2014 Feb;142(2):409-14. doi: 10.1017/S095026881300071X. Epub 2013 Apr 24.

PMID:
23611401
36.

Remifentanil patient controlled analgesia versus epidural analgesia in labour. A multicentre randomized controlled trial.

Freeman LM, Bloemenkamp KW, Franssen MT, Papatsonis DN, Hajenius PJ, van Huizen ME, Bremer HA, van den Akker ES, Woiski MD, Porath MM, van Beek E, Schuitemaker N, van der Salm PC, Fong BF, Radder C, Bax CJ, Sikkema M, van den Akker-van Marle ME, van Lith JM, Lopriore E, Uildriks RJ, Struys MM, Mol BW, Dahan A, Middeldorp JM.

BMC Pregnancy Childbirth. 2012 Jul 2;12:63. doi: 10.1186/1471-2393-12-63.

37.

Analyses of multiple-site and concurrent Chlamydia trachomatis serovar infections, and serovar tissue tropism for urogenital versus rectal specimens in male and female patients.

Bax CJ, Quint KD, Peters RP, Ouburg S, Oostvogel PM, Mutsaers JA, Dörr PJ, Schmidt S, Jansen C, van Leeuwen AP, Quint WG, Trimbos JB, Meijer CJ, Morré SA.

Sex Transm Infect. 2011 Oct;87(6):503-7. doi: 10.1136/sti.2010.048173. Epub 2011 Aug 19.

PMID:
21856696
38.

Significantly higher serologic responses of Chlamydia trachomatis B group serovars versus C and I serogroups.

Verweij SP, Bax CJ, Quint KD, Quint WG, van Leeuwen AP, Peters RP, Oostvogel PM, Mutsaers JA, Dörr PJ, Pleijster J, Ouburg S, Morré SA.

Drugs Today (Barc). 2009 Nov;45 Suppl B:135-40.

PMID:
20011705
39.

Description of the ICTI consortium: an integrated approach to the study of Chlamydia trachomatis infection.

Morré SA, Spaargaren J, Ossewaarde JM, Land JA, Bax CJ, Dörr PJ, Oostvogel PM, Vanrompay D, Savelkoul PH, Pannekoek Y, van Bergen JE, Fennema HS, de Vries HJ, Crusius JB, Peña AS, Ito JI, Lyons JM.

Drugs Today (Barc). 2006 Mar;42 Suppl A:107-14. Review.

PMID:
16683050
40.

Chlamydia trachomatis heat shock protein 60 (cHSP60) antibodies in women without and with tubal pathology using a new commercially available assay.

Bax CJ, Dörr PJ, Trimbos JB, Spaargaren J, Oostvogel PM, Peña AS, Morré SA.

Sex Transm Infect. 2004 Oct;80(5):415-6. No abstract available.

41.

Comparison of serological assays for detection of Chlamydia trachomatis antibodies in different groups of obstetrical and gynecological patients.

Bax CJ, Mutsaers JA, Jansen CL, Trimbos JB, Dörr PJ, Oostvogel PM.

Clin Diagn Lab Immunol. 2003 Jan;10(1):174-6.

42.

Clinical characteristics of Chlamydia trachomatis infections in a general outpatient department of obstetrics and gynaecology in the Netherlands.

Bax CJ, Oostvogel PM, Mutsaers JA, Brand R, Craandijk M, Trimbos JB, Dörr PJ.

Sex Transm Infect. 2002 Dec;78(6):E6.

Supplemental Content

Support Center